comparemela.com

Latest Breaking News On - Herriot tabuteau - Page 3 : comparemela.com

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

20.02.2024 - Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309% Auvelity 4Q and full year 2023 net product sales of $49.0 million and $130.1 million, .

New-york
United-states
Herriot-tabuteau
Mark-jacobson
Darren-opland
Axsome-therapeutics-inc
Drug-administration
Development-pipeline
World-trade-center
Nasdaq
Corporate-communications
Axsome-therapeutics

vimarsana © 2020. All Rights Reserved.